A Study of Niraparib Combined With MGD013 in Patients With Advanced or Metastatic Solid Tumor Who Failed Prior Treatment
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Gastric Cancer|Triple Negative Breast Cancer|Biliary Tract Carcinoma|Endometrial Carcinoma
Interventions: DRUG: Niraparib combined with MGD013
Sponsor: Zai Lab (Shanghai) Co., Ltd.